Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Growth, tolerance, and DHA and ARA status of healthy term infants receiving formula with two different ARA
D R Hoffman1, C L Harris2, J L Wampler2
1Retina Foundation of the Southwest, 9600 North Central Expressway, Dallas, TX 75231, United States.
Insights
Infant formulas with varying arachidonic acid (ARA) levels and prebiotics were found to be equivalent in providing docosahexaenoic acid (DHA) and ARA to infants. Buccal cells are not a reliable substitute for red blood cells in assessing fatty acid status.
Area of Science:
- Nutritional Science
- Pediatric Nutrition
- Biochemistry
Background:
- Docosahexaenoic acid (DHA) and arachidonic acid (ARA) are crucial long-chain polyunsaturated fatty acids (LC-PUFAs) for infant development.
- Red blood cell (RBC) fatty acid composition is a key indicator of nutritional status.
Purpose of the Study:
- To assess the equivalence of infant formulas with different ARA concentrations and prebiotic blends on DHA and ARA status.
- To evaluate the correlation between RBC and buccal epithelial cell fatty acid levels.
Main Methods:
- Healthy term infants received one of three formulas: Control (34 mg ARA/100 kcal), ARA-25 (25 mg ARA/100 kcal), or PDX/GOS (34 mg ARA/100 kcal with prebiotics).
- Fatty acid profiles in RBCs, plasma phospholipids (PPLs), and buccal epithelial cells were analyzed using gas chromatography.
- Statistical analysis included calculating confidence intervals for formula equivalence and correlation coefficients between different tissue types.
Main Results:
- All tested formulas demonstrated equivalence in providing DHA and ARA to infants, with RBC fatty acid levels falling within pre-specified equivalence limits (85-118%).
- No significant correlation was found between RBC and buccal epithelial cell ARA levels at 120 days.
- A low but significant correlation was observed for DHA between RBC and buccal epithelial cells.
Conclusions:
- Infant formulas with 25 or 34 mg ARA/100 kcal and 17 mg DHA/100 kcal support equivalent fatty acid status in infants.
- Buccal epithelial cells are not a suitable substitute for RBCs in assessing infant fatty acid status.
- The study supports the availability of DHA for infant brain development across the tested formula variations.
Abstract:
Circulating docosahexaenoic acid (DHA) and arachidonic acid (ARA) in total red blood cells (RBC) are considered indicators of fatty acid status. In this study, healthy term infants received study formula through 120 days of age. All study formulas had 17 mg DHA/100 kcal. Investigational formulas had 1) 25 g ARA/100 kcal and no added prebiotic blend (ARA-25; n = 29) or 2) 34 mg ARA/100 kcal and a prebiotic blend (1:1 ratio; 4 g/L) of polydextrose and galactooligosaccharides (PDX/GOS; n = 20). The control formula had 34 mg ARA/100 kcal and no added prebiotic blend (Control: n = 31). Fatty acids in total RBCs and plasma phospholipids (PPLs) at 120 days and buccal epithelial PLs at 14 and 120 days of age were assessed by capillary column gas chromatography. The calculated 90% confidence interval (CI) of each investigational formula relative to the Control for total RBC ARA (ARA-25: 93-105%; PDX/GOS: 96-110%) and total RBC DHA (ARA-25: 95-113%; PDX/GOS: 94-113%) fell within the pre-specified equivalence limit (85-118%), establishing study formula equivalence with respect to ARA and DHA. At day 120, total RBC and buccal epithelia PL ARA (µg/ml) were not significantly correlated (r = 0.041; p = 0.732); correlation in total RBC and buccal epithelia PL DHA was low, albeit significant (r = 0.324; p = 0.006). Consequently, buccal epithelial may not provide a suitable substitute for RBC when assessing fatty acid status and availability. The present RBC data suggest availability of DHA for central nervous system development and function is equivalent among infants receiving formulas that had 34 or 25 mg/100 kcal ARA and 17 mg/100 kcal DHA.
More Related Videos
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
03:53Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
Related Concept Videos
Blind Procedures
Chemical Formulas
Molecular Compounds: Formulas and Nomenclature
Ionic Compounds: Formulas and Nomenclature
Calculating Equilibrium Concentrations
A more...
Methods for Controlling Microbial Growth